Presidio Capital Management »

Fs Global Cr Opportunitie Fda shares owned by Presidio Capital Management

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Presidio Capital Management from 13F filings

Historical chart of Presidio Capital Management investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Presidio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Presidio Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $196k 35k 5.67
2023-09-30 $188k 35k 5.42
2023-06-30 $193k 41k 4.75
2023-03-31 $116k 26k 4.44
2022-12-31 $54k 12k 4.71

More positions owned by Presidio Capital Management

Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Direxion Shs Etf Tr Nas100 Eql Wgt (QQQE)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
First Tr Exchange-traded Senior Ln Fd (FTSL)
Invesco Exchange Traded Fd T Aerospace Defn (PPA)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr Core S&p Mcp Etf (IJH)
Apple (AAPL)
General Dynamics Corporation (GD)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)

View all positions for Presidio Capital Management

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Nomura Holdings
Cambridge Investment Research Advisors
Thomas J. Herzfeld Advisors
Saba Capital Management
Wagner Wealth Management
Penserra Capital Management
Advisor Group Holdings
H D Vest Advisory Services
Rockefeller Capital Management
Royal Bank of Canada
Kestra Advisory Services
Ellis Investment Partners
Prime Capital Investment Advisors
Feltz Wealth PLAN

View all funds holding Fs Global Cr Opportunitie Fda